An analysis of the top 25 lab tests across five countries revealed strong similarities in volume, revenue, and reimbursement, with pathology and biochemical tests exhibiting the highest and lowest payment rates, respectively. Most of these tests are on the Essential Diagnostics List (EDL), a factor that could help guide universal…